StockData
TuHURA Biosciences, Inc./NV logo

TuHURA Biosciences, Inc./NV (HURA) stock

HURANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$1.37−0.03 (-2.14%)

Close on Nov 18, 2026Market cap $87.31MP/E –Yield –

TuHURA Biosciences enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

TuHURA Biosciences's enterprise value was $95.80M on Nov 11, 2026, against $99.81M a year earlier. Over the last 5 years it ranged from -$10.55M to $142.48M, with a median of -$297.25K.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$95.80M+165.5%
2025Dec 31, 2025$36.09M–
2024Dec 31, 2024-$1.35M–
2023Dec 29, 2023-$1.26M-229.7%
2022Dec 30, 2022$971.74K–
2021Dec 31, 2021-$3.93M–
2020Dec 31, 2020-$6.17M–
2019Dec 31, 2019-$5.40M–
2018Dec 31, 2018-$3.69M-449.9%
2017Dec 29, 2017$1.06M–
2016Dec 30, 2016-$1.73M-153.0%
2015Dec 31, 2015$3.27M+45.7%
2014Dec 31, 2014$2.24M+0.5%
2013Dec 31, 2013$2.23M–

More TuHURA Biosciences figures

See a number that looks wrong?